Recursion Pharmaceuticals offers 61.5M shares
- 61,540,000 shares of Class A Common Stock
- Offering price $3.25 per share
- Total proceeds $188M before expenses
Every EDGAR filing for RECURSION PHARMACEUTICALS, INC. (RXRX), newest first, with AI summaries and stories.
Next: earnings expected ~Nov 5 · 10-Q expected ~Nov 5 (deadline Nov 9)
No open-market insider buys in the last 30 days.
Also: 2 open-market sales ($367K), 3 grants or exercises.
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
Robert Hershberg, insider filing for RXRX
Robert Hershberg, reporting
Robert Hershberg, planned sale of RXRX shares
Robert Hershberg
Dean Y Li, insider filing for RXRX
Dean Y Li
Ben R Taylor, insider filing for RXRX
Ben R Taylor, reporting
Najat Khan, insider filing for RXRX
Najat Khan, reporting
Najat Khan, planned sale of RXRX shares
Najat Khan, reporting
Blake Borgeson, insider filing for RXRX
Blake Borgeson, reporting
Blake Borgeson, planned sale of RXRX shares
Blake Borgeson, reporting
Christopher Gibson, planned sale of RXRX shares
Christopher Gibson, reporting
Christopher Gibson, planned sale of RXRX shares
Christopher Gibson, reporting
Christopher Gibson, planned sale of RXRX shares
Christopher Gibson, reporting
Ben R Taylor, insider filing for RXRX
Ben R Taylor, reporting
Christopher Gibson, planned sale of RXRX shares
Christopher Gibson, reporting
Christopher Gibson, planned sale of RXRX shares
Christopher Gibson, reporting
Christopher Gibson, planned sale of RXRX shares
Christopher Gibson, reporting
Christopher Gibson, planned sale of RXRX shares
Christopher Gibson, reporting
Christopher Gibson, planned sale of RXRX shares
Christopher Gibson, reporting
Ownership stake disclosure by STATE STREET CORP
STATE STREET CORP, filed by
Blake Borgeson, insider filing for RXRX
Blake Borgeson, reporting
Blake Borgeson, planned sale of RXRX shares
Blake Borgeson, reporting
Christopher Gibson, planned sale of RXRX shares
Christopher Gibson, reporting
Ownership stake disclosure by VANGUARD PORTFOLIO MANAGEMENT LLC
VANGUARD PORTFOLIO MANAGEMENT LLC, filed by
Christopher Gibson, planned sale of RXRX shares
Christopher Gibson, reporting
Christopher Gibson, planned sale of RXRX shares
Christopher Gibson, reporting
Ownership stake disclosure by BlackRock, Inc. (amended)
BlackRock, Inc., filed by
Christopher Gibson, planned sale of RXRX shares
Christopher Gibson, reporting
Christopher Gibson, planned sale of RXRX shares
Christopher Gibson, reporting
Christopher Gibson, planned sale of RXRX shares
Christopher Gibson, reporting
Christopher Gibson, planned sale of RXRX shares
Christopher Gibson, reporting
Christopher Gibson, planned sale of RXRX shares
Christopher Gibson, reporting
Christopher Gibson, planned sale of RXRX shares
Christopher Gibson, reporting
Christopher Gibson, planned sale of RXRX shares
Christopher Gibson, reporting
Christopher Gibson, planned sale of RXRX shares
Christopher Gibson, reporting
Christopher Gibson, planned sale of RXRX shares
Christopher Gibson, reporting
Blake Borgeson, insider filing for RXRX
Blake Borgeson, reporting
Christopher Gibson, planned sale of RXRX shares
Christopher Gibson, reporting
Christopher Gibson, planned sale of RXRX shares
Christopher Gibson, reporting
Christopher Gibson, planned sale of RXRX shares
Christopher Gibson, reporting